[ad_1]
The Corona vaccine field manufactured by the University of Oxford and AstraZeneca Company, a UK pharmaceutical company, is now approved in Bangladesh. Bangladesh will receive this vaccine from the Seram Institute of India. Meanwhile, India has approved the use of Covishield in an emergency. The UK has previously approved the vaccine.
To obtain approval, Beximco Pharmaceuticals Limited, which is contracted as the importer of the vaccine, must submit an application to the government Department of Drug Administration. Along with this, you need to provide the necessary information and data. They will be reviewed by two committees of the Drug Administration Department. The department will give final approval based on its decision.
According to relevant sources, Beximco has already started the application process. After the approval process is complete, the company will send a letter to the best of India. Seram will complete the necessary export process from that country and ship the vaccine to Bangladesh. Then the importer will deliver it to the government health department. After that, the distribution and application stage. No one can say for sure how long the vaccine will take to complete, although Health and Family Welfare Minister Zahid Malek has been insisting for two or three days that the Oxford vaccine arrive in January. He even hinted last Wednesday that the vaccine could be available before the end of January.
General Director of the Drug Administration Department, Major General. Mahbubur Rahman told Kaler Kantha: ‘We are now waiting for the application. We have to apply from Beximco, which we have not received yet (until yesterday afternoon). Once the request is received, we will forward it to the two scheduled committees for review. He added: “We are ready. It will not take long to get the application. One committee will only review various aspects, including the effectiveness and safety of the vaccine. Another committee will study the necessary technical aspects. The final decision will be made on the recommendation of the two committees.
Rabbur Reza, CEO of Beximco, told Kaler Kanth last night: “We made a request last Thursday. Now every now and then when the Serum data comes back to us, I’ll send it back. Even after that, if the drug administration wants another app, I’ll definitely give it to them.
According to a source from the Department of Drug Administration, Beximco has already submitted some 9,000 pages of data. However, as the Seram Institute has not yet received the approval letter from the Government of India, the application is not accepted as complete. Once everything is in hand, it will be considered as a formal request. According to multiple sources from the Department of Health and Beximco Pharma, there are plans to collect 5 million doses from the first batch of vaccines as planned before mid-January, or at least in the near future.
Meanwhile, the Department of Health is also preparing for the final stage of vaccination. Preparations will be completed within this week.
Additional Director General of the Department of Health (Planning and Development) Professor. “Now we are waiting for the country to approve the vaccine,” Mirzadi Sebrina Flora told Kaler Kanth. Also, our micro plan will be finalized in the next two days; This includes where and how we will administer the vaccine, how the vaccine will be distributed and stored, who will administer the vaccine, how easily the vaccine will be prioritized, everything. ” He said that tomorrow (January 5) there will be a meeting on registration.
Dr. Flora said: ‘We will vaccinate government institutions in the first step. Then the issue of private hospitals will come. A private hospital asked us to get vaccinated. But how they get it, how they give it to people, will be fixed in no time.
On the other hand, the covacin vaccine from India Biotech, a state-owned company, was approved in India shortly after the Oxford vaccine was approved, although the vaccine has caused controversy in India. India Biotech has claimed that their vaccine is completely safe. The other party, however, claimed that their proof was not sufficient.
Bharat Biotech submitted an application to test its vaccine in Bangladesh. But the government has not made any decision on the matter. The International Center for Diarrhea Research, Bangladesh (ICDDRB) was discussing the vaccine trial. But in the meantime, the vaccine has been approved in India. In this situation, it has come to light whether there is a need to test for covacin in Bangladesh.
A vaccine expert from the country’s government, who spoke on condition of anonymity, told Kaler Kanth that since the controversy broke out in India, the idea of importing and producing biotechnology vaccines from India has stumbled. On the other hand, since the Oxford vaccine has been approved in the United Kingdom, it does not need approval from the World Health Organization in accordance with the policy of the Government of Bangladesh regarding the importation of medicines. But that is not the case for India Biotech. Although the vaccine is safe, Bangladesh cannot import it without approval from the World Health Organization.
[ad_2]
